CELLvo™ Matrix Plus is a novel extracellular matrix derived from human cells that improves relevancy of cell culture studies The new cell culture substrate from StemBioSys supports isolation and culture of various cell types, including pluripotent cells. SAN ANTONIO, TX, March 24, 2020 – CELLvo™ Matrix Plus, a new extracellular matrix product from StemBioSys, Inc., […]
The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including […]
Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass. — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and […]
Genovis’ Nomination Committee proposes new election of Torben Jørgensen to serve on the Board of Directors and as Chairman of the Board at the Annual General Meeting on May 5. Torben Jørgensen was born in 1952 and is currently Chairman of the Board of Biotage AB and Atlas Antibodies AB. He also serves on the […]
Company Builds Leadership Team for Next Stage of Growth with Expanded Commercialization of Organs-on-Chips Product Suite BOSTON, Mass. – March 19, 2020 – Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s Board of Directors. These life science […]
After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences (“PacBio”) in this litigation. During the trial, the jury heard evidence that PacBio had never performed nanopore sequencing, before or after they filed patents that allegedly cover nanopore […]
HAYWARD, Calif., — Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced availability of its CleanPlex® SARS-CoV-2 Panel for COVID-19 coronavirus detection, tracking and research via amplicon-based target enrichment for NGS applications. The highly multiplexed target enrichment panel covers the entire genome of the SARS-CoV-2 virus […]
BOSTON, Mass. — Emulate, Inc. today announced that the company has completed the 150th installation of its Zoë® instrument, part of a lab-ready platform for Organs-on-Chips technology for use by researchers across many industries, particularly with early adopters conducting R&D related to drug discovery and development. Emulate has expanded its portfolio of commercially available Zoë-compatible […]
Beckman Coulter Life Sciences Revolutionizes Nanoparticle Analysis, Enabling Characterization Down To 40 nm With Launch of CytoFLEX nano Flow Cytometer Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points INDIANAPOLIS, USA − Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), […]
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a convenient new solution for the generation of 16S and StrainID amplicons The Shoreline Waveamplicon kit contains the same innovative amplification capabilities as the Shoreline Complete kit. It is a convenient solution for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

